logo BDSP

Base documentaire

  1. The cost of treating COPD patients with long-term oxygen therapy in a French population.

    Article - En anglais


    In greater Paris and its surroundings (as it is in all France), oxygen is home delivered by not-for-profit (NP) associations or profit-making (PM) health organizations.

    Both are financed by the national health insurance.

    This dual context and the current economic climate justify an economic evaluation of all respiratory care for patients with COPD receiving long-term oxygen therapy (LTO).

    This pragmatic approach identifies the variables that have the greatest impact on direct medical costs and estimates the annual cost for respiratory care per COPD patient.


    Retrospective study.


    Health insurance scheme for self-employed professionals (CANAM).

    Patients and methods 

    Between July 1985 and March 1994,234 patients registered in CANAM files began LTO, 24% in the PM sector, 76% in the NP sector, mainly using concentrator (78%), mean age of 74±10 years, male predominance (74%), PaO2 of 56.2±10.5 mm Hg, FEV1/FVC of 43±15%, and 51% having 1 or more severe illness (es) associated.

    The economic appraisal was performed on a representative sample of 61 patients and measured the total resources consumption for respiratory care per COPD patient and per year (physician visits and tests, drugs, physiotherapy, oxygen therapy, hospitalizations for acute respiratory failure, transport costs).


    A quarter of the patients in each sector did not meet the LTO prescription guidelines (PaO2>60 mm Hg). (...)

    Mots-clés Pascal : Bronchopneumopathie obstructive, Chronique, Oxygénothérapie, Ventilation assistée, A domicile, Analyse avantage coût, Evaluation, Economie santé, France, Europe, Traitement, Homme, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie, Réanimation respiratoire

    Mots-clés Pascal anglais : Obstructive pulmonary disease, Chronic, Oxygenotherapy, Assisted ventilation, At home, Cost benefit analysis, Evaluation, Health economy, France, Europe, Treatment, Human, Respiratory disease, Lung disease, Bronchus disease, Respiratory intensive care

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0405433

    Code Inist : 002B27A02. Création : 10/04/1997.